1aaf › Citations

Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1.

Summers MF, Henderson LE, Chance MR, Bess JW, South TL, Blake PR, Sagi I, Perez-Alvarado G, Sowder RC, Hare DR
Protein Sci 1 563-74 (1992)
Cited: 190 times
EuropePMC logo PMID: 1304355

Abstract

All retroviral nucleocapsid (NC) proteins contain one or two copies of an invariant 3Cys-1His array (CCHC = C-X2-C-X4-H-X4-C; C = Cys, H = His, X = variable amino acid) that are essential for RNA genome packaging and infectivity and have been proposed to function as zinc-binding domains. Although the arrays are capable of binding zinc in vitro, the physiological relevance of zinc coordination has not been firmly established. We have obtained zinc-edge extended X-ray absorption fine structure (EXAFS) spectra for intact retroviruses in order to determine if virus-bound zinc, which is present in quantities nearly stoichiometric with the CCHC arrays (Bess, J.W., Jr., Powell, P.J., Issaq, H.J., Schumack, L.J., Grimes, M.K., Henderson, L.E., & Arthur, L.O., 1992, J. Virol. 66, 840-847), exists in a unique coordination environment. The viral EXAFS spectra obtained are remarkably similar to the spectrum of a model CCHC zinc finger peptide with known 3Cys-1His zinc coordination structure. This finding, combined with other biochemical results, indicates that the majority of the viral zinc is coordinated to the NC CCHC arrays in mature retroviruses. Based on these findings, we have extended our NMR studies of the HIV-1 NC protein and have determined its three-dimensional solution-state structure. The CCHC arrays of HIV-1 NC exist as independently folded, noninteracting domains on a flexible polypeptide chain, with conservatively substituted aromatic residues forming hydrophobic patches on the zinc finger surfaces. These residues are essential for RNA genome recognition, and fluorescence measurements indicate that at least one residue (Trp37) participates directly in binding to nucleic acids in vitro. The NC is only the third HIV-1 protein to be structurally characterized, and the combined EXAFS, structural, and nucleic acid-binding results provide a basis for the rational design of new NC-targeted antiviral agents and vaccines for the control of AIDS.

Reviews - 1aaf mentioned but not cited (1)

  1. Overview of protein structural and functional folds. Sun PD, Foster CE, Boyington JC. Curr Protoc Protein Sci Chapter 17 Unit 17.1 (2004)

Articles - 1aaf mentioned but not cited (6)

  1. POPS: A fast algorithm for solvent accessible surface areas at atomic and residue level. Cavallo L, Kleinjung J, Fraternali F. Nucleic Acids Res 31 3364-3366 (2003)
  2. Flexible segments modulate co-folding of dUTPase and nucleocapsid proteins. Németh-Pongrácz V, Barabás O, Fuxreiter M, Simon I, Pichová I, Rumlová M, Zábranská H, Svergun D, Petoukhov M, Harmat V, Klement E, Hunyadi-Gulyás E, Medzihradszky KF, Kónya E, Vértessy BG. Nucleic Acids Res 35 495-505 (2007)
  3. Anthranilic acid-containing cyclic tetrapeptides: at the crossroads of conformational rigidity and synthetic accessibility. Xin D, Burgess K. Org Biomol Chem 14 5049-5058 (2016)
  4. Computational Design of Epitope-Enriched HIV-1 Gag Antigens with Preserved Structure and Function for Induction of Broad CD8+ T Cell Responses. Asbach B, Meier JP, Pfeifer M, Köstler J, Wagner R. Sci Rep 8 11264 (2018)
  5. Letter Native, sequential protein folding via anchored N and C protein termini. Alberti S. Proc Natl Acad Sci U S A 113 E3189-91 (2016)
  6. A Novel Framework for Ab Initio Coarse Protein Structure Prediction. Dubey SP, Balaji S, Kini NG, Sathish Kumar M. Adv Bioinformatics 2018 7607384 (2018)


Reviews citing this publication (31)

  1. HIV-1 gag proteins: diverse functions in the virus life cycle. Freed EO. Virology 251 1-15 (1998)
  2. HIV-1: fifteen proteins and an RNA. Frankel AD, Young JA. Annu Rev Biochem 67 1-25 (1998)
  3. HIV-1 assembly, release and maturation. Freed EO. Nat Rev Microbiol 13 484-496 (2015)
  4. How retroviruses select their genomes. D'Souza V, Summers MF. Nat Rev Microbiol 3 643-655 (2005)
  5. Structural biology of HIV. Turner BG, Summers MF. J Mol Biol 285 1-32 (1999)
  6. Structural determinants and mechanism of HIV-1 genome packaging. Lu K, Heng X, Summers MF. J Mol Biol 410 609-633 (2011)
  7. Mechanisms of retroviral recombination. Negroni M, Buc H. Annu Rev Genet 35 275-302 (2001)
  8. Properties and functions of the nucleocapsid protein in virus assembly. Muriaux D, Darlix JL. RNA Biol 7 744-753 (2010)
  9. Protein intrinsic disorder as a flexible armor and a weapon of HIV-1. Xue B, Mizianty MJ, Kurgan L, Uversky VN. Cell Mol Life Sci 69 1211-1259 (2012)
  10. HIV type 1 Gag as a target for antiviral therapy. Waheed AA, Freed EO. AIDS Res Hum Retroviruses 28 54-75 (2012)
  11. A structural perspective of RNA recognition by intrinsically disordered proteins. Basu S, Bahadur RP. Cell Mol Life Sci 73 4075-4084 (2016)
  12. Nucleocapsid Protein: A Desirable Target for Future Therapies Against HIV-1. Mori M, Kovalenko L, Lyonnais S, Antaki D, Torbett BE, Botta M, Mirambeau G, Mély Y. Curr Top Microbiol Immunol 389 53-92 (2015)
  13. Protein-RNA recognition. De Guzman RN, Turner RB, Summers MF. Biopolymers 48 181-195 (1998)
  14. Retroviral Gag protein-RNA interactions: Implications for specific genomic RNA packaging and virion assembly. Olson ED, Musier-Forsyth K. Semin Cell Dev Biol 86 129-139 (2019)
  15. Applications of real-time immuno-polymerase chain reaction (rt-IPCR) for the rapid diagnoses of viral antigens and pathologic proteins. Barletta J. Mol Aspects Med 27 224-253 (2006)
  16. Retrospective on the all-in-one retroviral nucleocapsid protein. Darlix JL, de Rocquigny H, Mauffret O, Mély Y. Virus Res 193 2-15 (2014)
  17. Towards the structure of the human immunodeficiency virus: divide and conquer. Wilk T, Fuller SD. Curr Opin Struct Biol 9 231-243 (1999)
  18. Design of alpha-helical peptides: their role in protein folding and molecular biology. Parthasarathy R, Chaturvedi S, Go K. Prog Biophys Mol Biol 64 1-54 (1995)
  19. Advances in targeting nucleocapsid-nucleic acid interactions in HIV-1 therapy. Garg D, Torbett BE. Virus Res 193 135-143 (2014)
  20. Cross- and Co-Packaging of Retroviral RNAs and Their Consequences. Ali LM, Rizvi TA, Mustafa F. Viruses 8 E276 (2016)
  21. Co-chairman's remarks: protein designs for the specific recognition of DNA. Klug A. Gene 135 83-92 (1993)
  22. Secondary interactions involving zinc-bound ligands: roles in structural stabilization and macromolecular interactions. Namuswe F, Berg JM. J Inorg Biochem 111 146-149 (2012)
  23. Gene regulatory proteins and their interaction with DNA. Klug A. Ann N Y Acad Sci 758 143-160 (1995)
  24. Host and Viral Zinc-Finger Proteins in COVID-19. Esposito S, D'Abrosca G, Antolak A, Pedone PV, Isernia C, Malgieri G. Int J Mol Sci 23 3711 (2022)
  25. How Do Flaviviruses Hijack Host Cell Functions by Phase Separation? Saito A, Shofa M, Ode H, Yumiya M, Hirano J, Okamoto T, Yoshimura SH. Viruses 13 1479 (2021)
  26. Viral Membrane Fusion Proteins and RNA Sorting Mechanisms for the Molecular Delivery by Exosomes. Zubarev I, Vladimirtsev D, Vorontsova M, Blatov I, Shevchenko K, Zvereva S, Lunev EA, Faizuloev E, Barlev N. Cells 10 3043 (2021)
  27. Retroviral nucleocapsid proteins and DNA strand transfers. René B, Mauffret O, Fossé P. Biochim Open 7 10-25 (2018)
  28. The HIV-1 Gag Protein Displays Extensive Functional and Structural Roles in Virus Replication and Infectivity. Marie V, Gordon ML. Int J Mol Sci 23 7569 (2022)
  29. Zinc finger structure determination by NMR: Why zinc fingers can be a handful. Neuhaus D. Prog Nucl Magn Reson Spectrosc 130-131 62-105 (2022)
  30. NMR Studies of Retroviral Genome Packaging. Boyd PS, Brown JB, Brown JD, Catazaro J, Chaudry I, Ding P, Dong X, Marchant J, O'Hern CT, Singh K, Swanson C, Summers MF, Yasin S. Viruses 12 E1115 (2020)
  31. New Insights into HIV Life Cycle, Th1/Th2 Shift during HIV Infection and Preferential Virus Infection of Th2 Cells: Implications of Early HIV Treatment Initiation and Care. Hokello J, Tyagi K, Owor RO, Sharma AL, Bhushan A, Daniel R, Tyagi M. Life (Basel) 14 104 (2024)

Articles citing this publication (152)

  1. In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. Campbell S, Rein A. J Virol 73 2270-2279 (1999)
  2. NMR structure of the HIV-1 nucleocapsid protein bound to stem-loop SL2 of the psi-RNA packaging signal. Implications for genome recognition. Amarasinghe GK, De Guzman RN, Turner RB, Chancellor KJ, Wu ZR, Summers MF. J Mol Biol 301 491-511 (2000)
  3. Conservation of the heterochronic regulator Lin-28, its developmental expression and microRNA complementary sites. Moss EG, Tang L. Dev Biol 258 432-442 (2003)
  4. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. Dorfman T, Luban J, Goff SP, Haseltine WA, Göttlinger HG. J Virol 67 6159-6169 (1993)
  5. The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. Gorelick RJ, Chabot DJ, Rein A, Henderson LE, Arthur LO. J Virol 67 4027-4036 (1993)
  6. Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo. Berkowitz RD, Ohagen A, Höglund S, Goff SP. J Virol 69 6445-6456 (1995)
  7. Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms. Yeager M, Wilson-Kubalek EM, Weiner SG, Brown PO, Rein A. Proc Natl Acad Sci U S A 95 7299-7304 (1998)
  8. Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays. Berkowitz RD, Luban J, Goff SP. J Virol 67 7190-7200 (1993)
  9. Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues. Dannull J, Surovoy A, Jung G, Moelling K. EMBO J 13 1525-1533 (1994)
  10. Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA. Guo J, Henderson LE, Bess J, Kane B, Levin JG. J Virol 71 5178-5188 (1997)
  11. Zinc finger structures in the human immunodeficiency virus type 1 nucleocapsid protein facilitate efficient minus- and plus-strand transfer. Guo J, Wu T, Anderson J, Kane BF, Johnson DG, Gorelick RJ, Henderson LE, Levin JG. J Virol 74 8980-8988 (2000)
  12. Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds. Rice WG, Schaeffer CA, Harten B, Villinger F, South TL, Summers MF, Henderson LE, Bess JW, Arthur LO, McDougal JS. Nature 361 473-475 (1993)
  13. Dynamical behavior of the HIV-1 nucleocapsid protein. Lee BM, De Guzman RN, Turner BG, Tjandra N, Summers MF. J Mol Biol 279 633-649 (1998)
  14. Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract. Wu W, Henderson LE, Copeland TD, Gorelick RJ, Bosche WJ, Rein A, Levin JG. J Virol 70 7132-7142 (1996)
  15. Actin-binding cellular proteins inside human immunodeficiency virus type 1. Ott DE, Coren LV, Johnson DG, Kane BP, Sowder RC, Kim YD, Fisher RJ, Zhou XZ, Lu KP, Henderson LE. Virology 266 42-51 (2000)
  16. Lowering the detection limits of HIV-1 viral load using real-time immuno-PCR for HIV-1 p24 antigen. Barletta JM, Edelman DC, Constantine NT. Am J Clin Pathol 122 20-27 (2004)
  17. Structure of the complex between the HIV-1 nucleocapsid protein NCp7 and the single-stranded pentanucleotide d(ACGCC). Morellet N, Déméné H, Teilleux V, Huynh-Dinh T, de Rocquigny H, Fournié-Zaluski MC, Roques BP. J Mol Biol 283 419-434 (1998)
  18. HIV-1 nucleocapsid protein activates transient melting of least stable parts of the secondary structure of TAR and its complementary sequence. Bernacchi S, Stoylov S, Piémont E, Ficheux D, Roques BP, Darlix JL, Mély Y. J Mol Biol 317 385-399 (2002)
  19. The role of nucleocapsid of HIV-1 in virus assembly. Dawson L, Yu XF. Virology 251 141-157 (1998)
  20. Mechanistic insights into the kinetics of HIV-1 nucleocapsid protein-facilitated tRNA annealing to the primer binding site. Hargittai MR, Gorelick RJ, Rouzina I, Musier-Forsyth K. J Mol Biol 337 951-968 (2004)
  21. Ordered aggregation of ribonucleic acids by the human immunodeficiency virus type 1 nucleocapsid protein. Stoylov SP, Vuilleumier C, Stoylova E, De Rocquigny H, Roques BP, Gérard D, Mély Y. Biopolymers 41 301-312 (1997)
  22. Conformational behaviour of the active and inactive forms of the nucleocapsid NCp7 of HIV-1 studied by 1H NMR. Morellet N, de Rocquigny H, Mély Y, Jullian N, Déméné H, Ottmann M, Gérard D, Darlix JL, Fournie-Zaluski MC, Roques BP. J Mol Biol 235 287-301 (1994)
  23. Effects of nucleocapsid mutations on human immunodeficiency virus assembly and RNA encapsidation. Zhang Y, Barklis E. J Virol 71 6765-6776 (1997)
  24. Structural basis of pre-let-7 miRNA recognition by the zinc knuckles of pluripotency factor Lin28. Loughlin FE, Gebert LF, Towbin H, Brunschweiger A, Hall J, Allain FH. Nat Struct Mol Biol 19 84-89 (2011)
  25. Structural insight into the zinc finger CW domain as a histone modification reader. He F, Umehara T, Saito K, Harada T, Watanabe S, Yabuki T, Kigawa T, Takahashi M, Kuwasako K, Tsuda K, Matsuda T, Aoki M, Seki E, Kobayashi N, Güntert P, Yokoyama S, Muto Y. Structure 18 1127-1139 (2010)
  26. Identification and characterisation of a developmentally regulated mammalian gene that utilises -1 programmed ribosomal frameshifting. Shigemoto K, Brennan J, Walls E, Watson CJ, Stott D, Rigby PW, Reith AD. Nucleic Acids Res 29 4079-4088 (2001)
  27. Subtle alterations of the native zinc finger structures have dramatic effects on the nucleic acid chaperone activity of human immunodeficiency virus type 1 nucleocapsid protein. Guo J, Wu T, Kane BF, Johnson DG, Henderson LE, Gorelick RJ, Levin JG. J Virol 76 4370-4378 (2002)
  28. Analysis and localization of cyclophilin A found in the virions of human immunodeficiency virus type 1 MN strain. Ott DE, Coren LV, Johnson DG, Sowder RC, Arthur LO, Henderson LE. AIDS Res Hum Retroviruses 11 1003-1006 (1995)
  29. Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA. Gorelick RJ, Chabot DJ, Ott DE, Gagliardi TD, Rein A, Henderson LE, Arthur LO. J Virol 70 2593-2597 (1996)
  30. The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is critical for virion structure and infectivity. Ottmann M, Gabus C, Darlix JL. J Virol 69 1778-1784 (1995)
  31. Solution structure of the RBCC/TRIM B-box1 domain of human MID1: B-box with a RING. Massiah MA, Simmons BN, Short KM, Cox TC. J Mol Biol 358 532-545 (2006)
  32. Zinc- and sequence-dependent binding to nucleic acids by the N-terminal zinc finger of the HIV-1 nucleocapsid protein: NMR structure of the complex with the Psi-site analog, dACGCC. South TL, Summers MF. Protein Sci 2 3-19 (1993)
  33. Evidence that a central domain of nucleocapsid protein is required for RNA packaging in murine leukemia virus. Rein A, Harvin DP, Mirro J, Ernst SM, Gorelick RJ. J Virol 68 6124-6129 (1994)
  34. Regulation of a specific circadian clock output pathway by lark, a putative RNA-binding protein with repressor activity. Newby LM, Jackson FR. J Neurobiol 31 117-128 (1996)
  35. Retroviral nucleocapsid proteins possess potent nucleic acid strand renaturation activity. Dib-Hajj F, Khan R, Giedroc DP. Protein Sci 2 231-243 (1993)
  36. Flexibility in the P2 domain of the HIV-1 Gag polyprotein. Newman JL, Butcher EW, Patel DT, Mikhaylenko Y, Summers MF. Protein Sci 13 2101-2107 (2004)
  37. Properties and growth mechanism of the ordered aggregation of a model RNA by the HIV-1 nucleocapsid protein: an electron microscopy investigation. Le Cam E, Coulaud D, Delain E, Petitjean P, Roques BP, Gérard D, Stoylova E, Vuilleumier C, Stoylov SP, Mély Y. Biopolymers 45 217-229 (1998)
  38. HIV-1 nucleocapsid protein zinc finger structures induce tRNA(Lys,3) structural changes but are not critical for primer/template annealing. Hargittai MR, Mangla AT, Gorelick RJ, Musier-Forsyth K. J Mol Biol 312 985-997 (2001)
  39. Binding properties of the human immunodeficiency virus type 1 nucleocapsid protein p7 to a model RNA: elucidation of the structural determinants for function. Urbaneja MA, Kane BP, Johnson DG, Gorelick RJ, Henderson LE, Casas-Finet JR. J Mol Biol 287 59-75 (1999)
  40. How the HIV-1 nucleocapsid protein binds and destabilises the (-)primer binding site during reverse transcription. Bourbigot S, Ramalanjaona N, Boudier C, Salgado GF, Roques BP, Mély Y, Bouaziz S, Morellet N. J Mol Biol 383 1112-1128 (2008)
  41. Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes. Malley SD, Grange JM, Hamedi-Sangsari F, Vila JR. Proc Natl Acad Sci U S A 91 11017-11021 (1994)
  42. Quantitation of HLA class II protein incorporated into human immunodeficiency type 1 virions purified by anti-CD45 immunoaffinity depletion of microvesicles. Trubey CM, Chertova E, Coren LV, Hilburn JM, Hixson CV, Nagashima K, Lifson JD, Ott DE. J Virol 77 12699-12709 (2003)
  43. Nanoparticle-Based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen. Tang S, Zhao J, Storhoff JJ, Norris PJ, Little RF, Yarchoan R, Stramer SL, Patno T, Domanus M, Dhar A, Mirkin CA, Hewlett IK. J Acquir Immune Defic Syndr 46 231-237 (2007)
  44. During the early phase of HIV-1 DNA synthesis, nucleocapsid protein directs hybridization of the TAR complementary sequences via the ends of their double-stranded stem. Godet J, de Rocquigny H, Raja C, Glasser N, Ficheux D, Darlix JL, Mély Y. J Mol Biol 356 1180-1192 (2006)
  45. Nucleic acid conformational changes essential for HIV-1 nucleocapsid protein-mediated inhibition of self-priming in minus-strand transfer. Hong MK, Harbron EJ, O'Connor DB, Guo J, Barbara PF, Levin JG, Musier-Forsyth K. J Mol Biol 325 1-10 (2003)
  46. Secondary structure and secondary structure dynamics of DNA hairpins complexed with HIV-1 NC protein. Cosa G, Harbron EJ, Zeng Y, Liu HW, O'Connor DB, Eta-Hosokawa C, Musier-Forsyth K, Barbara PF. Biophys J 87 2759-2767 (2004)
  47. Inhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins. Rice WG, Baker DC, Schaeffer CA, Graham L, Bu M, Terpening S, Clanton D, Schultz R, Bader JP, Buckheit RW, Field L, Singh PK, Turpin JA. Antimicrob Agents Chemother 41 419-426 (1997)
  48. An RNA structural switch regulates diploid genome packaging by Moloney murine leukemia virus. Miyazaki Y, Garcia EL, King SR, Iyalla K, Loeliger K, Starck P, Syed S, Telesnitsky A, Summers MF. J Mol Biol 396 141-152 (2010)
  49. The in vitro ejection of zinc from human immunodeficiency virus (HIV) type 1 nucleocapsid protein by disulfide benzamides with cellular anti-HIV activity. Tummino PJ, Scholten JD, Harvey PJ, Holler TP, Maloney L, Gogliotti R, Domagala J, Hupe D. Proc Natl Acad Sci U S A 93 969-973 (1996)
  50. The yeast Ty3 retrotransposon contains a 5'-3' bipartite primer-binding site and encodes nucleocapsid protein NCp9 functionally homologous to HIV-1 NCp7. Gabus C, Ficheux D, Rau M, Keith G, Sandmeyer S, Darlix JL. EMBO J 17 4873-4880 (1998)
  51. Cleavage of p15 protein in vitro by human immunodeficiency virus type 1 protease is RNA dependent. Sheng N, Erickson-Viitanen S. J Virol 68 6207-6214 (1994)
  52. Redox potential regulates binding of universal minicircle sequence binding protein at the kinetoplast DNA replication origin. Onn I, Milman-Shtepel N, Shlomai J. Eukaryot Cell 3 277-287 (2004)
  53. Transmission electron microscopy reveals an optimal HIV-1 nucleocapsid aggregation with single-stranded nucleic acids and the mature HIV-1 nucleocapsid protein. Mirambeau G, Lyonnais S, Coulaud D, Hameau L, Lafosse S, Jeusset J, Justome A, Delain E, Gorelick RJ, Le Cam E. J Mol Biol 364 496-511 (2006)
  54. A cobalt complex that selectively disrupts the structure and function of zinc fingers. Louie AY, Meade TJ. Proc Natl Acad Sci U S A 95 6663-6668 (1998)
  55. Metalloproteomics: high-throughput structural and functional annotation of proteins in structural genomics. Shi W, Zhan C, Ignatov A, Manjasetty BA, Marinkovic N, Sullivan M, Huang R, Chance MR. Structure 13 1473-1486 (2005)
  56. Targeting retroviral Zn finger-DNA interactions: a small-molecule approach using the electrophilic nature of trans-platinum-nucleobase compounds. Anzellotti AI, Liu Q, Bloemink MJ, Scarsdale JN, Farrell N. Chem Biol 13 539-548 (2006)
  57. The site of antiviral action of 3-nitrosobenzamide on the infectivity process of human immunodeficiency virus in human lymphocytes. Rice WG, Schaeffer CA, Graham L, Bu M, McDougal JS, Orloff SL, Villinger F, Young M, Oroszlan S, Fesen MR. Proc Natl Acad Sci U S A 90 9721-9724 (1993)
  58. High-throughput computational and experimental techniques in structural genomics. Chance MR, Fiser A, Sali A, Pieper U, Eswar N, Xu G, Fajardo JE, Radhakannan T, Marinkovic N. Genome Res 14 2145-2154 (2004)
  59. Elimination of retroviral infectivity by N-ethylmaleimide with preservation of functional envelope glycoproteins. Morcock DR, Thomas JA, Gagliardi TD, Gorelick RJ, Roser JD, Chertova EN, Bess JW, Ott DE, Sattentau QJ, Frank I, Pope M, Lifson JD, Henderson LE, Crise BJ. J Virol 79 1533-1542 (2005)
  60. Extended x-ray absorption fine structure studies of a retrovirus: equine infectious anemia virus cysteine arrays are coordinated to zinc. Chance MR, Sagi I, Wirt MD, Frisbie SM, Scheuring E, Chen E, Bess JW, Henderson LE, Arthur LO, South TL. Proc Natl Acad Sci U S A 89 10041-10045 (1992)
  61. Determination of the pK(a) of the four Zn2+-coordinating residues of the distal finger motif of the HIV-1 nucleocapsid protein: consequences on the binding of Zn2+. Bombarda E, Morellet N, Cherradi H, Spiess B, Bouaziz S, Grell E, Roques BP, Mély Y. J Mol Biol 310 659-672 (2001)
  62. Role of distal zinc finger of nucleocapsid protein in genomic RNA dimerization of human immunodeficiency virus type 1; no role for the palindrome crowning the R-U5 hairpin. Laughrea M, Shen N, Jetté L, Darlix JL, Kleiman L, Wainberg MA. Virology 281 109-116 (2001)
  63. Sampling a biomarker of the human immunodeficiency virus across a synthetic nanopore. Niedzwiecki DJ, Iyer R, Borer PN, Movileanu L. ACS Nano 7 3341-3350 (2013)
  64. Identification by high throughput screening of small compounds inhibiting the nucleic acid destabilization activity of the HIV-1 nucleocapsid protein. Shvadchak V, Sanglier S, Rocle S, Villa P, Haiech J, Hibert M, Van Dorsselaer A, Mély Y, de Rocquigny H. Biochimie 91 916-923 (2009)
  65. Inhibitory effects of archetypical nucleic acid ligands on the interactions of HIV-1 nucleocapsid protein with elements of Psi-RNA. Turner KB, Hagan NA, Fabris D. Nucleic Acids Res 34 1305-1316 (2006)
  66. Sensing peptide-oligonucleotide interactions by a two-color fluorescence label: application to the HIV-1 nucleocapsid protein. Shvadchak VV, Klymchenko AS, de Rocquigny H, Mély Y. Nucleic Acids Res 37 e25 (2009)
  67. Discovery and structural characterization of a new inhibitor series of HIV-1 nucleocapsid function: NMR solution structure determination of a ternary complex involving a 2:1 inhibitor/NC stoichiometry. Goudreau N, Hucke O, Faucher AM, Grand-Maître C, Lepage O, Bonneau PR, Mason SW, Titolo S. J Mol Biol 425 1982-1998 (2013)
  68. Immunomagnetic quantitative immuno-PCR for detection of less than one HIV-1 virion. Barletta J, Bartolome A, Constantine NT. J Virol Methods 157 122-132 (2009)
  69. HIV-1 Matrix Protein Interactions with tRNA: Implications for Membrane Targeting. Gaines CR, Tkacik E, Rivera-Oven A, Somani P, Achimovich A, Alabi T, Zhu A, Getachew N, Yang AL, McDonough M, Hawkins T, Spadaro Z, Summers MF. J Mol Biol 430 2113-2127 (2018)
  70. Investigating the mechanism of the nucleocapsid protein chaperoning of the second strand transfer during HIV-1 DNA synthesis. Ramalanjaona N, de Rocquigny H, Millet A, Ficheux D, Darlix JL, Mély Y. J Mol Biol 374 1041-1053 (2007)
  71. Simple diffusion-constrained immunoassay for p24 protein with the sensitivity of nucleic acid amplification for detecting acute HIV infection. Chang L, Song L, Fournier DR, Kan CW, Patel PP, Ferrell EP, Pink BA, Minnehan KA, Hanlon DW, Duffy DC, Wilson DH. J Virol Methods 188 153-160 (2013)
  72. Inactivation of murine leukemia virus by compounds that react with the zinc finger in the viral nucleocapsid protein. Rein A, Ott DE, Mirro J, Arthur LO, Rice W, Henderson LE. J Virol 70 4966-4972 (1996)
  73. Mechanism of multivalent nanoparticle encounter with HIV-1 for potency enhancement of peptide triazole virus inactivation. Rosemary Bastian A, Nangarlia A, Bailey LD, Holmes A, Kalyana Sundaram RV, Ang C, Moreira DR, Freedman K, Duffy C, Contarino M, Abrams C, Root M, Chaiken I. J Biol Chem 290 529-543 (2015)
  74. Structural and dynamic characterization of the aromatic amino acids of the human immunodeficiency virus type I nucleocapsid protein zinc fingers and their involvement in heterologous tRNA(Phe) binding: a steady-state and time-resolved fluorescence study. Mély Y, Piémont E, Sorinas-Jimeno M, de Rocquigny H, Jullian N, Morellet N, Roques BP, Gérard D. Biophys J 65 1513-1522 (1993)
  75. Purification of proteins containing zinc finger domains using immobilized metal ion affinity chromatography. Voráčková I, Suchanová S, Ulbrich P, Diehl WE, Ruml T. Protein Expr Purif 79 88-95 (2011)
  76. The human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein zinc ejection activity of disulfide benzamides and benzisothiazolones: correlation with anti-HIV and virucidal activities. Tummino PJ, Harvey PJ, McQuade T, Domagala J, Gogliotti R, Sanchez J, Song Y, Hupe D. Antimicrob Agents Chemother 41 394-400 (1997)
  77. Kinetic analysis of the nucleic acid chaperone activity of the hepatitis C virus core protein. Sharma Kk, Didier P, Darlix JL, de Rocquigny H, Bensikaddour H, Lavergne JP, Pénin F, Lessinger JM, Mély Y. Nucleic Acids Res 38 3632-3642 (2010)
  78. Site-selective probing of cTAR destabilization highlights the necessary plasticity of the HIV-1 nucleocapsid protein to chaperone the first strand transfer. Godet J, Kenfack C, Przybilla F, Richert L, Duportail G, Mély Y. Nucleic Acids Res 41 5036-5048 (2013)
  79. Solution structure of the RNA binding domain in the human muscleblind-like protein 2. He F, Dang W, Abe C, Tsuda K, Inoue M, Watanabe S, Kobayashi N, Kigawa T, Matsuda T, Yabuki T, Aoki M, Seki E, Harada T, Tomabechi Y, Terada T, Shirouzu M, Tanaka A, Güntert P, Muto Y, Yokoyama S. Protein Sci 18 80-91 (2009)
  80. The zinc finger of nucleocapsid protein of Friend murine leukemia virus is critical for proviral DNA synthesis in vivo. Yu Q, Darlix JL. J Virol 70 5791-5798 (1996)
  81. Three-dimensional 1H NMR structure of the nucleocapsid protein NCp10 of Moloney murine leukemia virus. Déméné H, Jullian N, Morellet N, de Rocquigny H, Cornille F, Maigret B, Roques BP. J Biomol NMR 4 153-170 (1994)
  82. Wild-type and mutant HIV type 1 nucleocapsid proteins increase the proportion of long cDNA transcripts by viral reverse transcriptase. Drummond JE, Mounts P, Gorelick RJ, Casas-Finet JR, Bosche WJ, Henderson LE, Waters DJ, Arthur LO. AIDS Res Hum Retroviruses 13 533-543 (1997)
  83. Analysis of NCp7-dependent activation of HIV-1 cDNA integration and its conservation among retroviral nucleocapsid proteins. Poljak L, Batson SM, Ficheux D, Roques BP, Darlix JL, Käs E. J Mol Biol 329 411-421 (2003)
  84. HIV-1 inactivation by 4-vinylpyridine is enhanced by dissociating Zn(2+) from nucleocapsid protein. Morcock DR, Thomas JA, Sowder RC, Henderson LE, Crise BJ, Gorelick RJ. Virology 375 148-158 (2008)
  85. Human cellular nucleic acid-binding protein Zn2+ fingers support replication of human immunodeficiency virus type 1 when they are substituted in the nucleocapsid protein. McGrath CF, Buckman JS, Gagliardi TD, Bosche WJ, Coren LV, Gorelick RJ. J Virol 77 8524-8531 (2003)
  86. Importance of basic residues in binding of rous sarcoma virus nucleocapsid to the RNA packaging signal. Lee EG, Alidina A, May C, Linial ML. J Virol 77 2010-2020 (2003)
  87. Time-resolved fluorescence investigation of the human immunodeficiency virus type 1 nucleocapsid protein: influence of the binding of nucleic acids. Bombarda E, Ababou A, Vuilleumier C, Gérard D, Roques BP, Piémont E, Mély Y. Biophys J 76 1561-1570 (1999)
  88. Zinc finger-dependent HIV-1 nucleocapsid protein-TAR RNA interactions. Lee N, Gorelick RJ, Musier-Forsyth K. Nucleic Acids Res 31 4847-4855 (2003)
  89. Effects of the nature and concentration of salt on the interaction of the HIV-1 nucleocapsid protein with SL3 RNA. Athavale SS, Ouyang W, McPike MP, Hudson BS, Borer PN. Biochemistry 49 3525-3533 (2010)
  90. Identification of residues of the Moloney murine leukemia virus nucleocapsid critical for viral DNA synthesis in vivo. Gonsky J, Bacharach E, Goff SP. J Virol 75 2616-2626 (2001)
  91. Solution structure and backbone dynamics of Mason-Pfizer monkey virus (MPMV) nucleocapsid protein. Gao Y, Kaluarachchi K, Giedroc DP. Protein Sci 7 2265-2280 (1998)
  92. Characterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detection. Tang S, Zhao J, Wang A, Viswanath R, Harma H, Little RF, Yarchoan R, Stramer SL, Nyambi PN, Lee S, Wood O, Wong EY, Wang X, Hewlett IK. Clin Vaccine Immunol 17 1244-1251 (2010)
  93. Effects of temperature on the dynamic behaviour of the HIV-1 nucleocapsid NCp7 and its DNA complex. Ramboarina S, Srividya N, Atkinson RA, Morellet N, Roques BP, Lefèvre JF, Mély Y, Kieffer B. J Mol Biol 316 611-627 (2002)
  94. Reactive cysteine in the structural Zn(2+) site of the C1B domain from PKCα. Stewart MD, Igumenova TI. Biochemistry 51 7263-7277 (2012)
  95. Solution structure of the zinc finger HIT domain in protein FON. He F, Umehara T, Tsuda K, Inoue M, Kigawa T, Matsuda T, Yabuki T, Aoki M, Seki E, Terada T, Shirouzu M, Tanaka A, Sugano S, Muto Y, Yokoyama S. Protein Sci 16 1577-1587 (2007)
  96. Virus-encoded Zinc Fingers as Targets for Antiviral Chemotherapy. Rice WG, Turpin JA. Rev Med Virol 6 187-199 (1996)
  97. Zinc binding by retroviral integrase. McEuen AR, Edwards B, Koepke KA, Ball AE, Jennings BA, Wolstenholme AJ, Danson MJ, Hough DW. Biochem Biophys Res Commun 189 813-818 (1992)
  98. Characterization of a nucleocapsid-like region and of two distinct primer tRNALys,2 binding sites in the endogenous retrovirus Gypsy. Gabus C, Ivanyi-Nagy R, Depollier J, Bucheton A, Pelisson A, Darlix JL. Nucleic Acids Res 34 5764-5777 (2006)
  99. Design of in vitro symmetric complexes and analysis by hybrid methods reveal mechanisms of HIV capsid assembly. Yeager M. J Mol Biol 410 534-552 (2011)
  100. Target specificity of human immunodeficiency virus type 1 NCp7 requires an intact conformation of its CCHC N-terminal zinc finger. Ramboarina S, Druillennec S, Morellet N, Bouaziz S, Roques BP. J Virol 78 6682-6687 (2004)
  101. Molecular mechanism of the Zn2+-induced folding of the distal CCHC finger motif of the HIV-1 nucleocapsid protein. Bombarda E, Grell E, Roques BP, Mély Y. Biophys J 93 208-217 (2007)
  102. Solution structure of a pair of modules from the gelatin-binding domain of fibronectin. Bocquier AA, Potts JR, Pickford AR, Campbell ID. Structure 7 1451-1460 (1999)
  103. Structure of the zinc finger domain encompassing residues 13-51 of the nucleocapsid protein from simian immunodeficiency virus. Morellet N, Meudal H, Bouaziz S, Roques BP. Biochem J 393 725-732 (2006)
  104. Bone morphogenetic protein-4-induced activation of Xretpos is mediated by Smads and Olf-1/EBF associated zinc finger (OAZ). Shim S, Bae N, Han JK. Nucleic Acids Res 30 3107-3117 (2002)
  105. Like polarity ion/ion reactions enable the investigation of specific metal interactions in nucleic acids and their noncovalent assemblies. Turner KB, Monti SA, Fabris D. J Am Chem Soc 130 13353-13363 (2008)
  106. Specificity of phage display selected peptides for modified anticodon stem and loop domains of tRNA. Eshete M, Marchbank MT, Deutscher SL, Sproat B, Leszczynska G, Malkiewicz A, Agris PF. Protein J 26 61-73 (2007)
  107. Insulin receptor alpha-subunit: a putative gene regulatory molecule. Radulescu RT. Med Hypotheses 45 107-111 (1995)
  108. Nucleocapsid protein annealing of a primer-template enhances (+)-strand DNA synthesis and fidelity by HIV-1 reverse transcriptase. Kim J, Roberts A, Yuan H, Xiong Y, Anderson KS. J Mol Biol 415 866-880 (2012)
  109. Replacement of His23 by Cys in a zinc finger of HIV-1 NCp7 led to a change in 1H NMR-derived 3D structure and to a loss of biological activity. Julian N, Demene H, Morellet N, Maigret B, Roques BP. FEBS Lett 331 43-48 (1993)
  110. Rotational dynamics of HIV-1 nucleocapsid protein NCp7 as probed by a spin label attached by peptide synthesis. Zhang Z, Xi X, Scholes CP, Karim CB. Biopolymers 89 1125-1135 (2008)
  111. The solution structure of ZNF593 from Homo sapiens reveals a zinc finger in a predominantly unstructured protein. Hayes PL, Lytle BL, Volkman BF, Peterson FC. Protein Sci 17 571-576 (2008)
  112. DNA binding properties of the zinc-bound and zinc-free HIV nucleocapsid protein: supercoiled DNA unwinding and DNA-protein cleavable complex formation. Priel E, Aflalo E, Seri I, Henderson LE, Arthur LO, Aboud M, Segal S, Blair DG. FEBS Lett 362 59-64 (1995)
  113. NMR relaxation studies of an RNA-binding segment of the rous sarcoma virus gag polyprotein in free and bound states: a model for autoinhibition of assembly. Taylor GM, Ma L, Vogt VM, Post CB. Biochemistry 49 4006-4017 (2010)
  114. Analysis of nucleic acid chaperoning by the prion protein and its inhibition by oligonucleotides. Guichard C, Ivanyi-Nagy R, Sharma KK, Gabus C, Marc D, Mély Y, Darlix JL. Nucleic Acids Res 39 8544-8558 (2011)
  115. Human ZCCHC12 activates AP-1 and CREB signaling as a transcriptional co-activator. Li H, Liu Q, Hu X, Feng D, Xiang S, He Z, Hu X, Zhou J, Ding X, Zhou C, Zhang J. Acta Biochim Biophys Sin (Shanghai) 41 535-544 (2009)
  116. Human nucleotide excision repair protein XPA: extended X-ray absorption fine-structure evidence for a metal-binding domain. Hess NJ, Buchko GW, Conradson SD, Espinosa FJ, Ni S, Thrall BD, Kennedy MA. Protein Sci 7 1970-1975 (1998)
  117. Inhibition of Friend virus replication by a compound that reacts with the nucleocapsid zinc finger: anti-retroviral effect demonstrated in vivo. Ott DE, Hewes SM, Alvord WG, Henderson LE, Arthur LO. Virology 243 283-292 (1998)
  118. Structural dynamics of retroviral genome and the packaging. Miyazaki Y, Miyake A, Nomaguchi M, Adachi A. Front Microbiol 2 264 (2011)
  119. The T12I mutation within the SP1 region of Gag restricts packaging of spliced viral RNA into human immunodeficiency virus type 1 with mutated RNA packaging signals and mutated nucleocapsid sequence. Roy BB, Russell RS, Turner D, Liang C. Virology 344 304-314 (2006)
  120. Characterization of a male specific region containing a candidate sex determining gene in Atlantic cod. Kirubakaran TG, Andersen Ø, De Rosa MC, Andersstuen T, Hallan K, Kent MP, Lien S. Sci Rep 9 116 (2019)
  121. Experimental determination and calculations of redox potential descriptors of compounds directed against retroviral zinc fingers: Implications for rational drug design. Topol IA, McGrath C, Chertova E, Dasenbrock C, Lacourse WR, Eissenstat MA, Burt SK, Henderson LE, Casas-Finet JR. Protein Sci 10 1434-1445 (2001)
  122. RNA recognition mechanism of the minimal active domain of the human immunodeficiency virus type-2 nucleocapsid protein. Matsui T, Kodera Y, Endoh H, Miyauchi E, Komatsu H, Sato K, Tanaka T, Kohno T, Maeda T. J Biochem 141 269-277 (2007)
  123. Antibody constant region: potential to bind metal and nucleic acid. Radulescu RT. Med Hypotheses 44 139-145 (1995)
  124. Interaction of retroviral nucleocapsid proteins with transfer RNAPhe: a lead ribozyme and 1H NMR study. Khan R, Chang HO, Kaluarachchi K, Giedroc DP. Nucleic Acids Res 24 3568-3575 (1996)
  125. Molecular determinants of HIV-1 NCp7 chaperone activity in maturation of the HIV-1 dimerization initiation site. Aduri R, Briggs KT, Gorelick RJ, Marino JP. Nucleic Acids Res 41 2565-2580 (2013)
  126. Mutations in the Basic Region of the Mason-Pfizer Monkey Virus Nucleocapsid Protein Affect Reverse Transcription, Genomic RNA Packaging, and the Virus Assembly Site. Dostálková A, Kaufman F, Křížová I, Kultová A, Strohalmová K, Hadravová R, Ruml T, Rumlová M. J Virol 92 e00106-18 (2018)
  127. Concurrent Exposure of Neutralizing and Non-neutralizing Epitopes on a Single HIV-1 Envelope Structure. Ray K, Mengistu M, Orlandi C, Pazgier M, Lewis GK, DeVico AL. Front Immunol 10 1512 (2019)
  128. Extended X-ray absorption fine structure evidence for a single metal binding domain in Xenopus laevis nucleotide excision repair protein XPA. Buchko GW, Iakoucheva LM, Kennedy MA, Ackerman EJ, Hess NJ. Biochem Biophys Res Commun 254 109-113 (1999)
  129. Unreported intrinsic disorder in proteins: Building connections to the literature on IDPs. Uversky VN. Intrinsically Disord Proteins 2 e970499 (2014)
  130. Congress 6th international symposium on retroviral nucleocapsid. Berkhout B, Gorelick R, Summers MF, Mély Y, Darlix JL. Retrovirology 5 21 (2008)
  131. An ultrasensitive planar array p24 Gag ELISA to detect HIV-1 in diverse biological matrixes. Levinger C, Howard JN, Cheng J, Tang P, Joshi A, Catalfamo M, Bosque A. Sci Rep 11 23682 (2021)
  132. Development of Monoclonal Antibodies against HIV-1 p24 Protein and Its Application in Colloidal Gold Immunochromatographic Assay for HIV-1 Detection. Ma Y, Ni C, Dzakah EE, Wang H, Kang K, Tang S, Wang J, Wang J. Biomed Res Int 2016 6743904 (2016)
  133. Metal cofactor modulated folding and target recognition of HIV-1 NCp7. Ren W, Ji D, Xu X. PLoS One 13 e0196662 (2018)
  134. Modulation of the HIV nucleocapsid dynamics finely tunes its RNA-binding properties during virion genesis. Mouhand A, Belfetmi A, Catala M, Larue V, Zargarian L, Brachet F, Gorelick RJ, Van Heijenoort C, Mirambeau G, Barraud P, Mauffret O, Tisné C. Nucleic Acids Res 46 9699-9710 (2018)
  135. Quantitative analysis of the formation of nucleoprotein complexes between HIV-1 Gag protein and genomic RNA using transmission electron microscopy. Durand S, Seigneuret F, Burlaud-Gaillard J, Lemoine R, Tassi MF, Moreau A, Mougel M, Roingeard P, Tauber C, de Rocquigny H. J Biol Chem 298 101500 (2022)
  136. Ty5 gag mutations increase retrotransposition and suggest a role for hydrogen bonding in the function of the nucleocapsid zinc finger. Gao X, Rowley DJ, Gai X, Voytas DF. J Virol 76 3240-3247 (2002)
  137. Across the Hall from Pioneers. Rein A. Viruses 13 491 (2021)
  138. Dengue virus strain 2 capsid protein switches the annealing pathway and reduces intrinsic dynamics of the conserved 5' untranslated region. Yong XE, Raghuvamsi PV, Anand GS, Wohland T, Sharma KK. RNA Biol 18 718-731 (2021)
  139. Evidence for stacking interactions between 5-mercurated polyuridylic acid and HIV-1 p7 nucleocapsid protein obtained by phosphorescence and optically detected magnetic resonance (ODMR). Lam WC, Maki AH, Casas-Finet JR, Erickson JW, Sowder RC, Henderson LE. FEBS Lett 328 45-48 (1993)
  140. Identification of a high affinity nucleocapsid protein binding element from the bovine leukemia virus genome. Yildiz FZ, Babalola K, Summers MF. Virus Res 171 278-286 (2013)
  141. Molecular mechanisms of simian immunodeficiency virus SIV(agm) RNA encapsidation. Fu W, Prasad VV, Chen J, Nikolaitchik O, Hu WS. Virology 363 210-219 (2007)
  142. Moloney murine leukemia virus genomic RNA packaged in the absence of a full complement of wild type nucleocapsid protein. Johnson SF, Garcia EL, Summers MF, Telesnitsky A. Virology 430 100-109 (2012)
  143. Pulse dipolar ESR of doubly labeled mini TAR DNA and its annealing to mini TAR RNA. Sun Y, Borbat PP, Grigoryants VM, Myers WK, Freed JH, Scholes CP. Biophys J 108 893-902 (2015)
  144. Spectroscopic study of an HIV-1 capsid protein major homology region peptide analog. Clish CB, Peyton DH, Barklis E. FEBS Lett 378 43-47 (1996)
  145. Standardization of a cytometric p24-capture bead-assay for the detection of main HIV-1 subtypes. Merbah M, Onkar S, Grivel JC, Vanpouille C, Biancotto A, Bonar L, Sanders-Buell E, Kijak G, Michael N, Robb M, Kim JH, Tovanabutra S, Chenine AL. J Virol Methods 230 45-52 (2016)
  146. Binding of human immunodeficiency virus type 1 nucleocapsid protein to psi-RNA-SL3. Shubsda MF, Kirk CA, Goodisman J, Dabrowiak JC. Biophys Chem 87 149-165 (2000)
  147. Cross-Subtype Detection of HIV-1 Capsid p24 Antigen Using a Sensitive Europium Nanoparticle Assay. Haleyur Giri Setty MK, Kurdekar A, Mahtani P, Liu J, Hewlett IK. AIDS Res Hum Retroviruses 35 396-401 (2019)
  148. Zinc-chelating postsynaptic density-95 N-terminus impairs its palmitoyl modification. Zhang Y, Fang X, Ascota L, Li L, Guerra L, Vega A, Salinas A, Gonzalez A, Garza C, Tsin A, Hell JW, Ames JB. Protein Sci 30 2246-2257 (2021)
  149. Application of ultrasensitive digital ELISA for p24 enables improved evaluation of HIV-1 reservoir diversity and growth kinetics in viral outgrowth assays. Kuzmichev YV, Lackman-Smith C, Bakkour S, Wiegand A, Bale MJ, Musick A, Bernstein W, Aronson N, Ake J, Tovanabutra S, Stone M, Ptak RG, Kearney MF, Busch MP, Wonderlich ER, Kulpa DA. Sci Rep 13 10958 (2023)
  150. Effect of mutation on the stabilization energy of HIV-1 zinc fingers: a hybrid local self-consistent field/molecular mechanics investigation. Drici N, Krallafa MA. J Biol Inorg Chem 22 109-119 (2017)
  151. Identification of Novel Nucleocapsid Chimeric Proteins Inhibiting HIV-1 Replication. Kim HI, Kim GN, Yu KL, Park SH, You JC. Int J Mol Sci 23 12340 (2022)
  152. The human cellular protein NoL12 is a specific partner of the HIV-1 nucleocapsid protein NCp7. Zgheib S, Taha N, Zeiger M, Glushonkov O, Lequeu T, Anton H, Didier P, Boutant E, Mély Y, Réal E. J Virol 97 e0004023 (2023)


Quick links